Physicians' Academy for Cardiovascular Education

Targeting Lp(a): therapeutic insights and novel developments

Listen to the podcast
10' education - Oct. 12, 2022 - Prof. Erik Stroes, MD, PhD - Amsterdam, The Netherlands

Video navigation menu

  • What's currently available to lower Lp(a)? 01:39
  • Novel strategies to lower Lp(a) 05:17
  • Summary 09:07


Show transcript

Educational information

This lecture by Prof. Erik Stroes was part of the EBAC-accredited symposium "Lp(a): from causality to therapy" held during the ESC congress 2022.


Prof. Erik Stroes, MD, PhD is professor of Vascular Medicine at Amsterdam University Medical Center in Amsterdam, The Netherlands.


This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.


Funding for this educational program was provided by unrestricted educational grants from NewAmsterdam Pharma, Novartis, Sanofi and Roche Diagnostics.

View the slides of this presentation

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: